MA41599A - Formes cristallines d'un composé pyrrolopyridine - Google Patents

Formes cristallines d'un composé pyrrolopyridine

Info

Publication number
MA41599A
MA41599A MA041599A MA41599A MA41599A MA 41599 A MA41599 A MA 41599A MA 041599 A MA041599 A MA 041599A MA 41599 A MA41599 A MA 41599A MA 41599 A MA41599 A MA 41599A
Authority
MA
Morocco
Prior art keywords
crystalline forms
pyrrolopyridine compound
pyrrolopyridine
compound
crystalline
Prior art date
Application number
MA041599A
Other languages
English (en)
Inventor
Christopher M Lindemann
Weidong Liu
Joseph Lubach
Keith L Spencer
Jeffrey Stults
Original Assignee
Array Biopharma Inc
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55521844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41599(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Array Biopharma Inc, Genentech Inc filed Critical Array Biopharma Inc
Publication of MA41599A publication Critical patent/MA41599A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA041599A 2015-02-26 2016-02-25 Formes cristallines d'un composé pyrrolopyridine MA41599A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562121396P 2015-02-26 2015-02-26

Publications (1)

Publication Number Publication Date
MA41599A true MA41599A (fr) 2018-01-02

Family

ID=55521844

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041599A MA41599A (fr) 2015-02-26 2016-02-25 Formes cristallines d'un composé pyrrolopyridine

Country Status (21)

Country Link
US (2) US20160251350A1 (fr)
EP (1) EP3262042A1 (fr)
JP (1) JP2018506562A (fr)
KR (1) KR20170118762A (fr)
CN (1) CN107406447A (fr)
AR (1) AR103801A1 (fr)
AU (1) AU2016225070A1 (fr)
BR (1) BR112017018230A2 (fr)
CA (1) CA2976665A1 (fr)
CL (1) CL2017002180A1 (fr)
CO (1) CO2017009662A2 (fr)
CR (1) CR20170439A (fr)
HK (1) HK1246786A1 (fr)
IL (1) IL254115A0 (fr)
MA (1) MA41599A (fr)
MX (1) MX2017010888A (fr)
PE (1) PE20171327A1 (fr)
PH (1) PH12017501532A1 (fr)
RU (1) RU2017133093A (fr)
SG (1) SG11201706824TA (fr)
WO (1) WO2016138458A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021014640A8 (pt) * 2019-01-29 2022-12-20 Huya Bioscience Int Llc Sais de sulcardina
WO2020167845A1 (fr) * 2019-02-12 2020-08-20 Impact Biomedicines, Inc. Formes cristallines d'un inhibiteur de jak2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
AR071717A1 (es) 2008-05-13 2010-07-07 Array Biopharma Inc Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
US8481557B2 (en) * 2009-04-11 2013-07-09 Array Biopharma Inc. Method of treatment using checkpoint kinase 1 inhibitors
CA2817968C (fr) * 2010-11-16 2019-03-12 Array Biopharma Inc. Combinaison d'inhibiteurs de la checkpoint kinase 1 et d'inhibiteurs de la wee 1 kinase
MX369174B (es) * 2013-08-22 2019-10-30 Genentech Inc Proceso para la preparación de un compuesto.
WO2015027090A1 (fr) * 2013-08-22 2015-02-26 Genentech, Inc. Intermédiaires et procédés pour la préparation de composés

Also Published As

Publication number Publication date
HK1246786A1 (zh) 2018-09-14
RU2017133093A (ru) 2019-03-26
JP2018506562A (ja) 2018-03-08
EP3262042A1 (fr) 2018-01-03
WO2016138458A1 (fr) 2016-09-01
CA2976665A1 (fr) 2016-09-01
CL2017002180A1 (es) 2018-03-16
CO2017009662A2 (es) 2018-02-28
RU2017133093A3 (fr) 2019-08-23
BR112017018230A2 (pt) 2018-04-17
PH12017501532A1 (en) 2018-02-05
US20180282324A1 (en) 2018-10-04
CR20170439A (es) 2018-01-08
CN107406447A (zh) 2017-11-28
KR20170118762A (ko) 2017-10-25
AR103801A1 (es) 2017-06-07
AU2016225070A1 (en) 2017-09-07
IL254115A0 (en) 2017-10-31
US20160251350A1 (en) 2016-09-01
MX2017010888A (es) 2017-12-15
SG11201706824TA (en) 2017-09-28
PE20171327A1 (es) 2017-09-12

Similar Documents

Publication Publication Date Title
EP3472168A4 (fr) Formes cristallines d'un composé de triazolopyrimidine
EP3541807A4 (fr) Formes cristallines d'un inhibiteur de magl
EP3619208C0 (fr) Formes cristallines d'un composé inhibiteur de jak
DK3372585T3 (da) Fremgangsmåde til fremstillingen af en diarylthiohydantoinforbindelse
EP3342777A4 (fr) Composé benzyle
SI3672965T1 (sl) Pirimidinska spojina kot zaviralec JAK-KINAZE
EP3560926A4 (fr) COMPOSÉ INHIBITEUR DE Brk
EP3354638A4 (fr) Composé de phtalonitrile
EP3789383A4 (fr) Composé de benzisoxazole
EP3299355A4 (fr) Composé de phtalonitrile
EP3372604A4 (fr) Composé hétérocyclique condensé
EP3337485A4 (fr) Formes cristallines d'ibrutinib
EP3533799A4 (fr) Composé
EP3438103A4 (fr) Composé de griséofulvine
DK3668835T3 (da) Fremgangsmåde til fremstilling af en monothiocarbonatforbindelse
LT3597189T (lt) Kristaliniai junginia
EP3404023A4 (fr) Composé bihétérocyclique
MA47129A (fr) Sel de composé pipéridine substitué
EP3678488A4 (fr) Nouveau composé herbicide
EP3808747A4 (fr) Composé d'imidazopyridinone
MA43275A (fr) Composé de pyranodipyridine
EP3375783A4 (fr) Composé hétérocyclique condensé
ZA201606653B (en) Solid forms of a pharmaceutically active compound
EP3380482A4 (fr) Formes cristallines d'un composé de thiénopyrimidine
EP3672972A4 (fr) Sels et formes cristallines d'un composé